Adrenergic theory: application to clinical and experimental surgery.
D018663:Adrenergic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000322:Adrenergic Agonists / Q000627:therapeutic use*; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002319:Cardiovascular System / Q000187:drug effects*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000188:drug therapy; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy; D013565:Sympatholytics / Q000627:therapeutic use*; D014666:Vasomotor System / Q000187:drug effects
D018663:Adrenergic Agents; D000322:Adrenergic Agonists; D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D011433:Propranolol